Literature DB >> 7585508

Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein.

C D Heinen1, D Richardson, R White, J Groden.   

Abstract

Almost 20% of colon cancers are characterized by genomic instability at simple repeated sequences. This instability is the result of a deficient DNA mismatch repair system. Sporadic, as well as hereditary carcinomas of the proximal colon display this effect. In this study, we examined colorectal adenocarcinoma cell lines, with or without wild-type adenomatous polyposis coli (APC) protein, for the presence of microsatellite instability. The three cell lines that maintained full-length APC protein also displayed the highest level of instability, suggesting a negative correlation between APC mutations and microsatellite instability. This data, in addition to other studies that show a negative correlation between microsatellite instability and mutations in p53 and K-ras, support the idea of a second pathway for colorectal cancer development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585508

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Mutation frequencies at codon 248 of the p53 tumour suppressor gene are not increased in colon cancer cell lines with the RER+ phenotype.

Authors:  T Mancuso; F Aguilar; M P Pescarolo; L Clerico; P Russo; S Parodi
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

3.  Alternative genetic pathways in colorectal carcinogenesis.

Authors:  S Olschwang; R Hamelin; P Laurent-Puig; B Thuille; Y De Rycke; Y J Li; F Muzeau; J Girodet; R J Salmon; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways.

Authors:  J R Jass; K G Biden; M C Cummings; L A Simms; M Walsh; E Schoch; S J Meltzer; C Wright; J Searle; J Young; B A Leggett
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

5.  Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum.

Authors:  J R Jass; H Iino; A Ruszkiewicz; D Painter; M J Solomon; D J Koorey; D Cohn; K L Furlong; M D Walsh; J Palazzo; T B Edmonston; R Fishel; J Young; B A Leggett
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

6.  Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum.

Authors:  J D Mueller; N Haegle; G Keller; E Mueller; G Saretzky; B Bethke; M Stolte; H Höfler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 7.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

8.  Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation.

Authors:  Slava Chtarbova; Inko Nimmrich; Silke Erdmann; Peter Herter; Matthias Renner; Jan Kitajewski; Oliver Müller
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

9.  Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.

Authors:  Margreet Lüchtenborg; Matty P Weijenberg; Petra A Wark; A Merdan Saritas; Guido M J M Roemen; Goos N P van Muijen; Adriaan P de Bruïne; Piet A van den Brandt; Anton F P M de Goeij
Journal:  BMC Cancer       Date:  2005-12-15       Impact factor: 4.430

10.  Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression.

Authors:  Laura Arce; Kira T Pate; Marian L Waterman
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.